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ABSTRACT: Although multivalent binding to surfaces is an important
tool in nanotechnology, quantitative information about the residual
valency and orientation of surface-bound molecules is missing. To address
these questions, we study streptavidin (SAv) binding to commonly used
biotinylated surfaces such as supported lipid bilayers (SLBs) and self-
assembled monolayers (SAMs). Stability and kinetics of SAv binding are
characterized by quartz crystal microbalance with dissipation monitoring,
while the residual valency of immobilized SAv is quantiﬁed using
spectroscopic ellipsometry by monitoring binding of biotinylated probes.
Purpose-designed SAv constructs having controlled valencies (mono-, di-,
trivalent in terms of biotin-binding sites) are studied to rationalize the
results obtained on regular (tetravalent) SAv. We ﬁnd that divalent interaction of SAv with biotinylated surfaces is a strict
requirement for stable immobilization, while monovalent attachment is reversible and, in the case of SLBs, leads to the extraction
of biotinylated lipids from the bilayer. The surface density and lateral mobility of biotin, and the SAv surface coverage are all
found to inﬂuence the average orientation and residual valency of SAv on a biotinylated surface. We demonstrate how the
residual valency can be adjusted to one or two biotin binding sites per immobilized SAv by choosing appropriate surface
chemistry. The obtained results provide means for the rational design of surface-conﬁned supramolecular architectures involving
speciﬁc biointeractions at tunable valency. This knowledge can be used for the development of well-deﬁned bioactive coatings,
biosensors and biomimetic model systems.
■ INTRODUCTION
Multivalent binding, through multiple interactions between
speciﬁc ligand/receptor pairs, is involved in a diversity of
biological interactions (e.g., antigen/antibody, cell/cell, cell/
virus) and cellular processes (e.g., adhesion, chemotaxis,
inﬂammation, secretion).1 Multivalent interactions are also an
attractive tool for the design of supramolecular architectures,
because they enable strong but reversible attachment, while
drastically increasing binding selectivity as compared to
monovalent bonds.2,3 Deﬁning the factors governing multi-
valent binding at interfaces is therefore important for
understanding biological systems and for the design of
supramolecular nanomaterials.1−3 In particular, the dependence
of multivalent self-assembly on surface properties (chemistry,
packing, lateral mobility) remains diﬃcult to assess.
Among numerous surface-binding approaches, the inter-
action between biotin and tetravalent SAv stands out by its high
aﬃnity (Kd ≈ 10−14 M
4) and speciﬁcity. In addition, the high
stability of SAv compared to most other proteins along with the
availability of eﬃcient methods for the biotinylation of
biological and synthetic molecules and nano-objects render
the SAv-biotin technology versatile and enable various
experimental designs. These features have made the SAv-biotin
pair widely used in biotechnology for labeling, detection and
puriﬁcation.5,6 In particular, SAv-mediated assembly at
interfaces (surface coatings, nanoparticles, membranes, etc.)
provided the basis for various supramolecular architectures
intended for biosensors,7−10 biospeciﬁc targeting,11 drug
delivery systems,12 bioactive coatings13,14 and biomimetic
model systems.15,16
In the majority of these architectures, SAv acts as a
multivalent linker that uses the same type of interaction to
bind to the surface and to attach desired molecules
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(proteins,7,9,17 nucleic acids,7,8,17,18 sugars,15,16 drugs13) or
nano-objects (vesicles,19,20 viruses,21 nanoparticles22) from the
solution phase. Composite ﬁlms, in which SAv functions as a
supramolecular glue to assemble multiple layers of nano-
objects, have also been realized.19,21 The eﬃciency of surface
functionalization and the stability of the whole surface-conﬁned
architecture depend in these systems on the residual valency,
i.e., the amount of biotin-binding sites that remain accessible
after SAv attachment to the surface.
Among the diﬀerent surface chemistry approaches, supported
lipid bilayers (SLBs)23 and self-assembled monolayers
(SAMs)8,24−27 are the most commonly used to study23−27
and to realize8,28 multivalent binding to surfaces. They can be
formed on various solid supports (metal/metal oxide, trans-
parent/opaque, conducting/insulating, planar macroscopic
surface/curved particle surface, etc.), which provides versatile
platforms to study multivalency eﬀects by diﬀerent surface
sensitive techniques and in a wide range of experimental
conditions.23,26,27 Combining SLBs and SAMs with established
conjugation chemistries (e.g., click alkyne/azide,26−28 His-tag/
NTA23) allows tuning of the nature and density of surface
binding sites, while keeping lateral mobility on (ﬂuid-phase
SLBs) or oﬀ (SAMs) depending on the experimental design.
In the case of SAv, many experiments have been performed
on SLBs containing laterally mobile biotinylated lipids (b-
SLBs).29−33 These revealed that SAv forms dense and stable
monolayers,29,31−33 which may evolve into two-dimensional
crystals,29,32,33 and divalent binding was proposed based on the
analysis of the crystal structure.29 Studies with SAMs containing
eﬀectively immobile biotinylated compounds (b-SAMs),
formed through thiol/metal34,35 or silane/metal oxide chem-
istries36 have also been reported.
Despite the common use, and the growing interest in the
SAv/biotin technology, our understanding of the parameters
that deﬁne the stability, the orientation and the residual valency
of SAv on biotinylated surfaces is still very limited. On the basis
of the symmetric structure of SAv, it is often assumed that SAv
binds with two binding sites to the surface and thus has a
residual valency of two.8,15,29,30,37 This assumption, however,
and the corresponding orientation of SAv on the surface are
rarely conﬁrmed experimentally. It has also been reported that
the strength of SAv-biotin binding on SAMs can be lower than
in the solution phase and depends on the nature of the SAM
and the surface density of biotin,34 illustrating that the SAv
binding depends sensitively on how biotin is presented by the
surface. One can expect the residual valency of SAv to depend
on the biotin surface density, and the ﬂexibility and/or lateral
mobility of binding sites may also inﬂuence the residual
valency.9 Moreover, solution studies revealed that the SAv-
biotin binding strength depends on the number and position of
the occupied binding pockets,38−40 and this may additionally
aﬀect SAv attachment to biotinylated surfaces. In particular,
substantial negative cooperativity due to steric hindrance was
found for large biotinylated ligands (e.g., DNA or proteins) in
the case of divalent binding with the occupied binding pockets
arranged in cis- but not when arranged in trans-orientation.38
Recognizing this complexity raises the question of the interplay
between surface chemistry and the residual valency of SAv, and
multivalent molecules in general.
Here, we address this question with a systematic and
quantitative analysis of SAv binding to both b-SAMs and b-
SLBs. The lateral mobility and surface density of biotin, and the
SAv surface coverage, are tuned and their inﬂuence on SAv-
biotin interactions is studied. The results obtained on regular
SAv are rationalized using purpose-designed synthetic SAv
Figure 1. Tunable model system to study SAv binding to biotinylated surfaces. (A) Table of tunable parameters. (B) SAv constructs having diﬀerent
valencies. On the left, the structure of the SAv tetramer (ribbon diagram with each monomer in distinct color) with biotins attached to its binding
pockets (ball-and-stick model) is shown; on the right, the SAv constructs used are listed schematically. (C−E) Fluorescence measurements in the
presence of biotin in solution reveal the number of binding sites in SAv constructs. (C) Relative ﬂuorescence emission intensity of tryptophan
located in the binding pockets of rSAv, tSAv, dSAv-trans, mSAv (ﬁlled squares, each data point represents a single measurement) and dSAv-cis
(empty triangle, mean of 2 measurements with standard error) upon biotin binding to saturation. All data fall onto a straight line (linear ﬁt) that
crosses the y axis at 100%. (D) Example of tryptophan relative intensity change upon biotin binding to SAv (the moment of biotin injection is
indicated by an arrow). This data set corresponds to the last point in (C). (E) Examples of ﬂuorescence spectra. Here, tryptophan ﬂuorescence
emission spectra of rSAv solution in the absence of biotin (blue) and 45 min after biotin injection (red) are shown, and the maxima in these spectra
correspond to the ﬁrst and last points, respectively, in (D). A negative control (i.e., biotin without SAv) is also shown (black).
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constructs having lower valencies but no change in binding
aﬃnity (Figure 1). We uncover that SAv can bind in several
distinct orientations and valencies to b-SAMs and b-SLBs, and
that the monovalent attachment of SAv on b-SLBs and b-SAMs
is generally unstable. We thus show that the spectrum of SAv
properties at surfaces is much richer than previously
appreciated, and demonstrate how this can be exploited to
tune the residual valency of SAv between one and two by
choosing appropriate surface chemistry and/or SAv immobili-
zation conditions.
■ EXPERIMENTAL SECTION
Materials. The SAv constructs used are schematically shown in
Figure 1B. Regular tetravalent streptavidin (rSAv, Mw ≈ 60 kDa) was
purchased from Sigma-Aldrich. Trivalent SAv (tSAv, 55.4 kDa),
divalent SAv with cis- (dSAv-cis, 55.2 kDa) and trans- (dSAv-trans,
54.6 kDa) orientations of biotin-binding sites and monovalent SAv
(mSAv, 53.8 kDa) were expressed in E. coli, refolded from inclusion
bodies, and puriﬁed by ion-exchange chromatography as previously
described.38 Dioleoylphosphatidylcholine (DOPC; 1 in Figure 2A)
and dioleoylphosphatidylethanolamine-CAP-biotin (DOPE-CAP-bio-
tin; 2 in Figure 2A) were purchased from Avanti Polar Lipids
(Alabaster, AL). HS-(CH2)11-EG4-OH (EG: ethylene glycol; 3 in
Figure 2B) and HS-(CH2)11-EG6-biotin (4 in Figure 2B) were
purchased from Prochimia (Sopot, Poland). Biotin and O-(2-
aminoethyl)-O′-[2-(biotinylamino)ethyl]octaethylene glycol (b-
OEG) were purchased from Sigma-Aldrich. An oligosaccharide of
HA with 15 monosaccharide units and a biotin at the reducing end (b-
oHA; 3.2 kDa; Figure 3) was produced through functionalization of an
HA pentadecasaccharide generated by an automated solid-phase
synthesis,41 puriﬁed by HPLC and characterized by MS and 1H NMR
(Supporting Methods and Figure S1). A tandem repeat of the Z
domain of protein A connected through a ﬂexible spacer (12 amino
acids) to an N-terminal biotin (b-ZZ, 16.2 kDa; Figure 3) was
expressed in E. coli, puriﬁed and characterized by SDS-PAGE
(Supporting Methods and Figure S2). 4.95 MHz QCM-D sensors
coated with gold (QSX301) or silica (QSX303) were purchased from
Biolin Scientiﬁc (Vas̈tra Frölunda, Sweden). Silicon wafers with a
native oxide ﬁlm were purchased from University Wafer (Boston,
MA). Silicon wafers with an opaque gold coating were purchased from
BT Electronics (Les Ulis, France). A working buﬀer made of 10 mM
HEPES, pH 7.4 and 150 mM NaCl was used for all QCM-D, SE and
ﬂuorescence measurements. All experiments were performed at room
temperature.
Quartz Crystal Microbalance with Dissipation Monitoring
(QCM-D) Measurements. QCM-D measurements were performed
Figure 2. Biotinylated surfaces with controlled lateral mobility and biotin content. (A) Schematic representation of a b-SLB, chemical structure of
lipids and a characteristic QCM-D signature of b-SLB formation using SUVs made of DOPC (1) and DOPE-CAP-biotin (2) at a 19:1 molar ratio.
The time of SUV exposure is indicated by an arrow. (B) Schematic representation of b-SAM, chemical structure of thiols and characteristic images of
water drops placed on a bare Au surface and on Au surfaces functionalized with HS-(CH2)11-EG4-OH (3) and its mixture with HS-(CH2)11-EG6-
biotin (4) at a 9:1 molar ratio with contact angles indicated.
Figure 3. Reporters for residual SAv valency. Schematic representation
of biotinylated probes, b-ZZ and b-oHA, used as reporters of the
residual valency of SAv bound to a biotinylated surface (in this case b-
SLB). The reporter probes are drawn approximately to scale with the
rSAv and the SLB thickness.
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in ﬂow mode at a ﬂow rate of 20 μL/min using a Q-Sense E4 system
equipped with four Q-Sense Flow Modules (Biolin Scientiﬁc). Silica-
coated sensors (for SLBs) or gold-coated sensors (functionalized ex
situ with SAMs) were used as substrates. Before injection, SAv, b-ZZ
and b-oHA were dissolved in working buﬀer to 10, 36, and 5 μg/mL
concentration, respectively. Overtones j = 3, 5, 7, 9, 11, and 13 were
recorded in addition to the fundamental resonance frequency (4.95
MHz). Changes in dissipation (ΔD) and normalized frequency, Δf =
Δf j/j, for j = 7 are presented; all other overtones would have provided
equivalent information.
Spectroscopic Ellipsometry (SE) Measurements. SE measure-
ments were performed on silicon wafers with a native oxide ﬁlm (for
SLBs) or with a gold coating (functionalized ex situ with SAMs) using
a spectroscopic rotating compensator ellipsometer (M-2000 V; J. A.
Woollam, Lincoln, NE) and a custom-made open cuvette (250 μL
volume) equipped with a magnetic stirrer for liquid homogenization
and connections to tubings for liquid ﬂow. Sample incubations were
performed in “batch mode” by injecting concentrated samples directly
into the buﬀer-ﬁlled cuvette under stirring (no ﬂow). SAv, b-ZZ and b-
oHA were incubated at ﬁnal concentrations of 10, 36, and 5 μg/mL,
respectively. Rinsing in working buﬀer was performed in “ﬂow mode”
at a ﬂow rate of 500 μL/min. The ellipsometric angles Δ and Ψ were
acquired over a wavelength range from λ = 380 to 1000 nm, at an
angle of incidence of 70°. Prior to measurements, we checked that the
polarization of the light beam was not aﬀected by the cuvette’s glass
windows as previously described.42 The refractive index n(λ) and
optical thickness d of the adsorbed ﬁlm were determined by ﬁtting the
ellipsometric data to a multilayer model, using the software
CompleteEASE (J. A. Woollam). The model relates the measured Δ
and Ψ as a function of λ to the optical properties of the substrate, the
adsorbed organic ﬁlm(s) and the surrounding solution. The semi-
inﬁnite bulk solution was treated as a transparent Cauchy medium,
with a refractive index nsol(λ) = Asol + Bsol/λ
2. For the surrounding
buﬀer solution, Asol = 1.325 and Bsol = 0.00322 μm
2 were used.42 The
opaque gold coating modiﬁed with SAM was treated as a
homogeneous substrate. Its eﬀective optical properties were
determined from data acquired in the presence of bulk solution but
in the absence of a protein ﬁlm, by ﬁtting the refractive index and
extinction coeﬃcient over the accessible λ range using a B-spline
algorithm implemented in CompleteEASE. The native oxide ﬁlm on Si
wafers was treated as transparent and homogeneous (Cauchy
medium), and its optical properties and thickness were determined
from data acquired in the presence of a bulk solution, which were
ﬁtted over the accessible λ range using tabulated values for the
underlying Si substrate (implemented in CompleteEASE). The
solvated organic ﬁlm was treated as a single layer, which we assumed
to be transparent and homogeneous (Cauchy medium), with a given d
and n(λ) = A + B/λ2. d and A were treated as ﬁtting parameters,
assuming B = Bsol. The χ
2 value for the best ﬁt was typically below 2,
indicating a good ﬁt. The adsorbed organic mass per unit area Γ was
determined from Γ = d(A − Asol)/(dn/dc), which is equivalent to de
Feijter’s equation,43 with refractive index increments dn/dc = 0.180
cm3/g for proteins43 and 0.150 cm3/g for b-oHA.44
Contact Angle Measurements. Contact angle measurements
were performed on a DSA100 Drop Shape Analyzer (KRÜSS,
Hamburg, Germany). Contact angles were calculated as mean and
standard deviation of six measurements, with 3 μL drops of ultrapure
water being positioned on diﬀerent places of the modiﬁed gold
surfaces.
Fluorescence Measurements. Fluorescence measurements were
performed with a FluoroLog ﬂuorometer (Horiba Jobin Yvon,
Longjumeau, France). Fluorescence emission spectra of SAv solutions
were recorded at λex = 280 nm in the range λem = 290 to 500 nm,
corresponding to the excitation and emission wavelengths of
tryptophan located in the biotin-binding pockets of SAv. Measure-
ments were performed in working buﬀer at 1.5 to 3.0 μg/mL SAv, with
10 to 20-fold excess of b-SUVs (in molar concentration of biotinylated
lipids per SAv tetramer) or 50-fold excess of biotin. The results are
presented in the form of relative ﬂuorescence intensity, that is (Imax/
Imax
0 ) × 100%, where Imax
0 and Imax are the maxima in the emission
spectra before and after biotin or b-SUV injection, respectively.
Formation of b-SLBs. Stock solutions at 2 mg/mL of small
unilamellar vesicles (SUVs) composed of pure DOPC, and of a
mixture of DOPC and DOPE-CAP-biotin (molar ratio 19:1), were
prepared in working buﬀer as previously described.45 Silica-coated
surfaces were cleaned by immersion in 2% sodium dodecyl sulfate
(SDS) aqueous solution (30 min), rinsing in ultrapure water and blow
drying in nitrogen gas, and activated by UV-ozone treatment (30 min).
SLBs were formed by the method of vesicle spreading,46 through 10
min exposure of 50 μg/mL SUVs in working buﬀer supplemented with
2 mM CaCl2 to freshly activated surfaces. The biotin content in the
SLBs was varied by mixing SUV stock solutions of pure DOPC and
DOPC/DOPC-CAP-biotin at desired ratios (0 to 5% ﬁnal molar
fraction of DOPC-CAP-biotin) prior to their dilution and exposure to
the substrate. Excess lipid material was removed from the bulk solution
by rinsing with working buﬀer.
Formation of b-SAMs. Mixed SAMs were formed following the
procedure developed for the HS-(CH2)11-EG4-OH/HS-(CH2)11-EG6-
azide thiol pair.28 The gold-coated surfaces were ﬁrst cleaned by UV-
ozone treatment (5 min) and immersion in ethanol (20 min) with
stirring, and then placed overnight in ethanol containing HS-(CH2)11-
EG4-OH and HS-(CH2)11-EG6-biotin (1 mM total concentration).
The molar fraction of HS-(CH2)11-EG6-biotin was varied from 0 to
10%. Excess thiols were removed by rinsing with ethanol, and the
substrate was blow dried with nitrogen gas.
■ RESULTS
Design and Characterization of SAv/Biotin Model
System. Our goal was to identify the relevant parameters
governing the binding stability, orientation and residual valency
of surface-attached SAv. To this end, we developed a tunable
model system (Figure 1A) based on a set of synthetic SAv
constructs (Figure 1B), biotinylated surfaces (Figure 2) and
biotinylated reporter probes (Figure 3).
Streptavidin Constructs. In addition to the regular
streptavidin (rSAv) with 4 biotin binding sites, synthetic SAv
constructs were designed to have 1 (mSAv), 2 (dSAv) or 3
(tSAv) binding sites, where two topologically distinct arrange-
ments (cis, trans) are provided for dSAv (Figure 1B).38 The
stoichiometry of SAv to biotin was veriﬁed by ﬂuorescence
spectroscopy, using the intrinsic ﬂuorescence of tryptophan in
SAv’s biotin-binding pockets as readout (Figure 1C−E).47,48
Four residues per pocket49 give 16 tryptophans per SAv
sequence eventually involved in biotin binding. The ﬂuo-
rescence intensity decreased upon addition of excess biotin to
the SAv solution (Figure 1D,E), as expected, and the linear
dependence of the change in peak ﬂuorescence intensity on the
nominal SAv valency (Figure 1C) conﬁrmed the expected
number of biotin-binding sites in all SAv constructs.
Biotinylated Surfaces. Contrary to SAMs, where each thiol
is chemically grafted to the gold surface,50 SLBs on silica allow
biotinylated lipids to diﬀuse along the surface with a rate of a
few μm2/s.51 Comparative assays with b-SLBs (“ﬂuid surface”)
and b-SAMs (“immobile surface”), therefore, enable us to
evaluate the eﬀect of biotin lateral mobility. SLBs and SAMs
were designed to display biotin at tunable surface densities
(Figure 2). To this end, the molar fraction of biotinylated lipids
and thiols was systematically varied in the ranges 0 ≤ x ≤ 5%
and 0 ≤ y ≤ 10%, respectively. The surface coatings thus
formed are denoted as bx-SLBs and by-SAMs. With a typical
molecular footprint of 60 Å2 per lipid49 and 28 Å2 per thiol28
one can estimate the root-mean-square (rms) distance between
biotins to be lb = 3.4 nm for b5%-SLBs, and 1.7 nm for b10%-
SAMs, where the latter corresponds to a surface density of 60
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pmol/cm2. We have here assumed that the molar fractions of
biotinylated molecules displayed on the surfaces are identical to
the molar fraction in the solutions from which the SLBs and
SAMs were assembled. In reality, some deviations may occur,
yet the numbers should represent a reasonable order-of-
magnitude estimate of the interbiotin distance at the maximal
biotin densities explored.
b-SLBs were composed of DOPC (1) and DOPE-CAP-
biotin (2), and their proper formation was ascertained by
QCM-D (Figure 2A). The two-phase responses in the
frequency shifts Δf and dissipation shifts ΔD are characteristic
for the self-assembly process that involves binding, spreading
and rupture of vesicles, and ultimately the coalescence of bilayer
patches into a conﬂuent SLB.46,52 b-SLBs of appropriate quality
are characterized by Δf = −25 ± 1 Hz and ΔD < 0.5 × 10−6 at
the end of the SLB formation process, and these were routinely
obtained irrespective of the molar fraction of biotinylated lipids.
b-SAMs were composed of HS-(CH2)11-EG4-OH (3) and
HS-(CH2)11-EG6-biotin (4), and their proper formation was
conﬁrmed by contact angle goniometry (Figure 2B). b-SAMs of
appropriate quality were characterized by contact angles that
decrease from 31 to 19° as the thiol-biotin fraction in solution
is increased from 0 to 10%, whereas bare gold had a much
larger contact angle (75°). Sample-to-sample reproducibility
was tested for b-SAMs prepared using 10% thiol-biotin, and the
relative standard deviation in the contact angle was 5.8% (19.1
± 1.1°, n = 17).
Biotinylated Reporter Probes. Two distinct biotinylated
probes were used as reporters for the mean residual valency of
surface-bound SAv (Figure 3). b-ZZ is a protein construct with
an N-terminal biotin followed by a ﬂexible linker (∼5 nm
contour length) and a tandem repeat of the Z domain of
protein A (∼3.5 nm diameter). b-ZZ was designed to have a
relatively large molecular weight (16.2 kDa) to facilitate high-
resolution surface density quantiﬁcation by SE while at the
same time being just small enough to assess all biotin-binding
sites on a SAv monolayer without appreciable steric hindrance
(the ﬂexible linker was inserted to facilitate b-ZZ binding into
narrow spaces between adjacent SAv molecules and further
alleviate packing constraints). b-oHA is a linear oligosaccharide
of hyaluronan (15 monosaccharides, contour length 7.5 nm)
connecting via a ﬂexible linker to biotin. The persistence length
of HA has been reported to lie between 4 to 8 nm,53 and oHA
can thus be pictured as a slightly bent rod (∼1 nm diameter).
With these dimensions, b-oHA binding should not suﬀer from
steric constraints even on the most densely packed SAv ﬁlms,
although its low molecular weight (3.2 kDa) limits somewhat
the surface density resolution by SE. We used b-oHA as an
additional reference to conﬁrm that b-ZZ binding to densely
packed SAv monolayers is quantitative, and more generally, to
validate the binding assays and quantify residual valencies with
two independent probes.
Control Measurements. Before embarking on a systematic
analysis, the speciﬁcity of binding to SLBs and SAMs was
ascertained. None of the SAv constructs bound in detectable
amounts to SLBs made from pure DOPC or to SAMs made
from pure HS-(CH2)11-EG4-OH, and neither did b-ZZ or b-
oHA, conﬁrming that nonspeciﬁc interactions are negligible in
our assays (Figure S3). We also veriﬁed that SAv, which
typically bound very stably to b-SLBs and b-SAMs (notable
exceptions are discussed below), was not released by
competition with biotinylated probes in the solution phase
(Figure S4). This conﬁrmed that the intended function of b-
Figure 4. Binding of monovalent SAv to biotinylated surfaces. (A,B) QCM-D responses recorded during the binding of mSAv, and subsequently b-
ZZ, to b10%-SAM (A) and b5%-SLB (B). Insets in A and B illustrate reversible mSAv binding and extraction of biotinylated lipids by mSAv,
respectively. (C) QCM-D responses obtained upon exposure of mSAv and subsequently rSAv and b-ZZ to a b1%-SLB (squares) together with a
control in which the exposure to mSAv was omitted (circles). The data indicate SAv-induced depletion of biotinylated lipids from the SLB, as
illustrated schematically. (D) Representative measurement of changes in tryptophan ﬂuorescence emission intensity upon injection of b5%-SUVs to
a solution of mSAv (injection time is indicated by an arrow). The inset shows mean and standard deviation of the relative intensity decrease at
equilibrium; the decrease is similar to that of free biotin in solution (Figure 1C) and indicates speciﬁc and quantitative binding of mSAv to
biotinylated lipids through the biotin-binding pocket of mSAv.
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oHA or b-ZZ to report the presence of free binding sites is not
compromised by adverse secondary eﬀects.
Next, we systematically studied SAv binding to b-SLBs and b-
SAMs. QCM-D was used to assess the occurring binding events
and the stability of SAv attachment (Figures 4, 5, and 8), while
quantitative information about the SAv surface density and
residual valency was obtained by SE (Figures 6 and 7). Among
all the tunable parameters in our system (Figure 1A), the SAv
concentration did not signiﬁcantly aﬀect the ﬁnal SAv coverage
and residual valency (Figure S5). All assays presented in the
following were thus performed at a ﬁxed SAv concentration (10
μg/mL).
Binding Stability, Orientation and Residual Valency at
High Surface Coverage. We ﬁrst studied the binding of SAv
on surfaces displaying high biotin densities, while tuning the
SAv valency and the lateral mobility of biotin. Figures 4A,B and
5 compare the QCM-D signatures obtained for diﬀerent SAv
constructs, and subsequent b-ZZ binding, to b10%-SAMs and
b5%-SLBs. Analogous measurements were performed with b-
oHA, and qualitatively similar responses were obtained (Figure
S6). Quantitative analysis by SE (Figure 6 and Table S1) also
showed comparable levels of b-ZZ and b-oHA binding on
dense SAv monolayers (e.g., on b10%-SAMs coated with rSAv
until saturation) conﬁrming that steric hindrance does not
restrict b-ZZ binding, and we thus used both b-ZZ and b-oHA
as reliable reporters of residual valency.
Stability of SAv Surface Attachment. We started with
mSAv as this enables the quality of monovalent interactions to
be directly assessed. When exposed to b10%-SAMs, mSAv
rapidly bound to equilibrium (Δf = −21 Hz) but slow release
occurred during rinsing in working buﬀer, and the release was
accelerated in the presence of competing biotinylated probes in
solution (Figures 4A and S6A). Upon exposure of mSAv to
b5%-SLBs, Δf decreased only slightly (by less than 3 Hz), and
the initial rapid decrease in Δf was followed by a slow but
signiﬁcant increase, indicating eﬀective release of material, even
Figure 5. Binding of multivalent SAv constructs to densely biotinylated surfaces. Shown are QCM-D responses recorded during the binding of SAv
constructs, and subsequently b-ZZ, to b10%-SAM (A) and b5%-SLB (B). Insets in A and B illustrate the surfaces and molecules used, and the
schematic representations in C illustrate the binding featuresresidual valency, reported by b-ZZ, and orientationof the diﬀerent SAv constructs.
Data are marked with distinct symbols for each SAv construct: rSAv (squares), tSAv (circles), dSAv-cis (upward-pointing triangles) and dSAv-trans
(downward-pointing triangles).
Figure 6. SAv binding and residual valency on densely biotinylated surfaces, quantiﬁed by SE. (A) Example of binding curves obtained by SE, here
for rSAv and b-oHA on a b5%-SLB. The inset illustrates the SE setup. (B) Table of surface densities of SAv, ΓSAv, and biotinylated reporter probes
(b-ZZ or b-oHA), Γb, and the mean residual valency, Γb/ΓSAv. Values are presented as mean ± error, where the latter is the sum of the
reproducibility error (4%; averaged from 4 independent sets of SE measurements with 2 to 4 samples in each set, cf. column 3 in Table S1) and the
detection limit of the SE (1 ng/cm2). aBinding was below the detection limit of SE; bmSAv removed biotinylated lipids from b-SLB (cf. Figure 4B);
cMeasured before buﬀer rinsing, as binding was not stable (cf. Figure 4A); db-ZZ accelerated displacement of mSAv from the surface. Conditions:
SAv adsorption time = 90 min, biotinylated probe adsorption time = 15−60 min. All values were determined after adsorption and buﬀer rinsing once
the SE response was stabilized, except for mSAv on SAMs, where the equilibrium bound amount before rinsing is given (as rinsing provokes mSAv
detachment, Figure 4A).
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in the presence of mSAv in the solution phase (Figure 4B).
Perhaps most strikingly, rSAv binding to b-SLBs was
completely impaired by preincubation of b-SLBs with mSAv
(Figure 4C). We veriﬁed by intrinsic ﬂuorescence spectroscopy
that mSAv retains the capacity of rSAv to bind biotinylated
lipids (Figure 4D). Collectively, these data demonstrate that
mSAv is unable to bind stably to both the immobile and the
ﬂuid biotinylated surfaces, but instead has the remarkable and
unexpected capacity to extract biotinylated lipids from lipid
bilayers (Figure 4B, inset).
In contrast to mSAv, all multivalent forms of SAv bound
stably to b10%-SAMs and b5%-SLBs (Figures 5 and S6). No
signiﬁcant desorption was observed upon rinsing in working
buﬀer, indicating that multivalent binding is both necessary and
suﬃcient for the quasi-irreversible attachment of SAv that is
desired in most practical applications.
Residual Valency and Orientation of Surface-Attached
SAv. Next, we used our biotinylated reporter probes (Figure 3)
to characterize the residual valency of multivalent SAv
constructs. Both QCM-D (Figures 5 and S6) and SE (Figure
6) data clearly showed that the reporter probes are unable to
bind divalent SAv, suggesting that both available biotin-binding
pockets are engaged in SAv attachment to the biotinylated
surfaces. These results eﬀectively demonstrate that two SAv
binding pockets can bind simultaneously to b-SAMs or b-SLBs
not only when they are arranged in cis but also when they are
arranged in trans positions (Figure 5C).
The magnitudes of the frequency shift for the reporter
probes were more than 2-fold smaller on tSAv than on rSAv
under otherwise identical conditions (Figures 5 and S6).
Equivalent measurements by SE (Figure 6B) revealed that the
mean residual valency of surface-attached tSAv was below 1.0,
whereas values between 1.0 and 2.0 were obtained for rSAv.
These results indicate that SAv can also bind to biotinylated
surfaces in a trivalent mode and that residual valencies of 0 and
1 for tSAv, and of 1 and 2 for rSAv, can coexist on the same b-
SLB or b-SAM surface (Figure 5C).
Packing Density of Surface-Attached SAv. There are
several subtle yet characteristic diﬀerences in the packing of
the multivalent SAv constructs on b-SAMs and b-SLBs. First,
|Δf SAv| values at saturation were larger on b-SLBs than on b-
SAMs for any of the SAv constructs. This reﬂects diﬀerences in
the packing density (Figures 6B and S7A), and most likely
arises from the ability of SAv to rearrange and thus pack more
tightly on the ﬂuid surface. Second, lower ΔD/−Δf values were
obtained on b-SAMs compared to b-SLBs (Figure S7B). For
globular proteins such as SAv, ΔD/−Δf is a measure of the
softness of the linker region that connects the protein with the
biotinylated surface,54 and the observed diﬀerence indicates a
tighter (and thus rigid) binding interface in the case of b-SAMs.
Finally, slightly higher |Δf SAv| values were obtained for rSAv
and dSAv-cis at saturation as compared to tSAv and dSAv-trans
(Figure 5). SE results conﬁrmed that this diﬀerence reﬂects
variations in the packing densities of the cis- and trans-oriented
SAv forms (Figures 6B and S7A).
Eﬀect of Surface Coverage on Binding Stability and
Residual Valency. In principle, the surface coverage of SAv
can be tuned in two distinct ways: by varying the SAv
incubation time or by varying the biotin surface density. We
thus performed two series of measurements to study how these
parameters inﬂuence the stability of SAv binding and the
residual valency. The SE results are summarized in Figure 7,
and additional QCM-D data are shown in Figures S8−S10.
Tuning SAv Incubation Time. First, we varied the protein
incubation time while maintaining the biotin surface density
high and unaltered. As expected, SAv coverage increased
steadily with SAv adsorption time (Figure S8A). We tested the
eﬀect of this approach on the residual valencies of tSAv and
rSAv on b5%-SLBs and b10%-SAMs.
On both ﬂuid and immobile surfaces, both SAv constructs
bound stably and the amount of bound biotinylated probes Γb
increased steadily with SAv surface coverage ΓSAv (Figure
S9A,B). On b-SAMs, the dependence was linear, as evidenced
by SE (for rSAv; Figure 7A, red) and QCM-D (for tSAv and
rSAv; Figure S10A). This implies that, for a given b-SAM, the
Figure 7. Eﬀect of SAv coverage, and biotin surface density on SAv binding to biotinylated surfaces. The surface density of the biotinylated reporter
probe vs the surface density of rSAv (squares) and tSAv (circles) was quantiﬁed by SE for immobile (A) and ﬂuid (B) surfaces. The SAv surface
density was tuned by varying either biotin surface density (incubating SAv to saturation or equilibrium; blue), or SAv adsorption time (on b10%-
SAMs and b5%-SLBs, respectively; red). All values were determined after adsorption and buﬀer rinsing once the SE response was stabilized. The
ratio Γb/ΓSAv (insets) corresponds to the mean residual valency of SAv. Lines are parabolic or linear ﬁts; dashed lines indicate the range where SAv
binding is not stable precluding quantiﬁcation of residual valency. Conditions: biotin surface fraction = 10% (A, red), 5% (B, red), tuned from 1 to
10% (A, blue) or from 0.45 to 5% (B, blue); SAv adsorption time−tuned from 10 s to 90 min (A and B, red), 90 min (A, blue), 30 min (B, blue);
biotinylated probe adsorption time = 15 to 60 min; see Table S1 for full details on conditions and determined values.
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mean residual valency is unaﬀected by the SAv surface density
(Γb/ΓrSAv = 1.7 on b10%-SAMs; Figure 7A, inset). This was not
the case on b-SLBs, where the dependence was supra-linear
(Figures 7B and S10B, red). Eﬀectively, the mean residual
valency increased with the SAv surface density (inset in Figure
7B, red). At the lowest (0.8 pmol/cm2) and highest (4.5 pmol/
cm2) rSAv densities tested by SE, Γb/ΓrSAv were 1.1 and 1.7,
respectively, implying that attachment varied from mainly
(90%) trivalent to mainly (70%) divalent. At the most extreme,
purely trivalent binding is observed, as illustrated by the
complete absence of b-ZZ attachment to dilute tSAv
monolayers on b5%-SLBs (Figure S9B).
Tuning Biotin Surface Density. In the second set of
measurements, we tested the binding of SAv on b-SLBs and b-
SAMs displaying diﬀerent densities of biotin with SAv being
incubated to saturation (or equilibrium) throughout. Diﬀerent
trends were observed on immobile and ﬂuid surfaces.
On immobile surfaces, not only the amount (Figure S8B,
blue) but also the stability of SAv binding was signiﬁcantly
aﬀected by biotin coverage, with partial detachment being
detected at biotin fractions below 1% even for the multivalent
SAv constructs (Figure 8A). The estimated rms distance
between biotins on a b1%-SAM is around 5 nm, which is
comparable to the spacing between binding pockets in SAv. It
can thus be expected that, due to steric constraints, most SAv
molecules ﬁnd only one biotin to attach to at lower biotin
content. We therefore attribute the reduced binding stability on
diluted b-SAMs to the lack of multivalent attachment, as
already revealed above for mSAv (Figure 4A). Completely
reversible binding of mSAv to b0.05%-SAMs (Figure 8B)
supports this interpretation. The higher apparent stability with
increasing SAv valency (at constant biotin surface density;
Figure 8A) and with increasing surface density (for mSAv;
Figures 4A and 8) can be explained by an increased probability
of rebinding to adjacent binding sites.55
Binding of the multivalent SAv constructs was essentially
stable for biotin fractions of 1% and larger. Quantiﬁcation
revealed mean residual valencies Γb/ΓrSAv = 1.95 and Γb/ΓtSAv =
0.85 on b1%-SAMs (Figure 7A, blue), close to the values of 2.0
and 1.0, respectively, expected for purely divalent attachment.
For b10%-SAMs, the values were reduced (to 1.76 and 0.74,
respectively), indicating that trivalent attachment becomes
increasingly important as the biotin fraction increases.
Consistent with this trend, we had previously reported an
even lower residual valency of Γb/ΓrSAv = 1.51 on b20%-SAMs
(using diﬀerent biotinylated probe and buﬀer).8
On ﬂuid surfaces, SAv bound stably irrespective of the biotin
content. As expected, the amount of bound SAv increased
steadily with the biotin density, with a plateau being attained at
about 1% (Figure S8B, red). Furthermore, SE and comple-
mentary QCM-D data (Figures 7B, S9C and S10B, blue)
revealed a supra-linear relationship between the amount of
bound SAv and subsequently bound biotinylated probe. One
can assume that, in the absence of steric hindrance, the
attachment of SAv to b-SLBs matures over time by recruiting
additional biotins, thus leading to a reduced residual valency.
This is similar to the case when the SAv incubation time was
varied, although the eﬀect is now less pronounced (compare
blue and red data for rSAv in Figure 7B, inset).
In summary, the systematic analysis (Figure 7) shows that
the mean residual valency of SAv bound to biotinylated surfaces
is determined by several factors, including lateral mobility,
biotin surface density and SAv coverage, and can be
experimentally adjusted, between 1 and 2 for rSAv and
between 0 and 1 for tSAv, by tuning one or several of these
parameters.
■ DISCUSSION
Stability of SAv Anchoring. Our ﬁndings on immobile
biotinylated surfaces demonstrate that the details of the binding
interface have an appreciable eﬀect on the stability of SAv
attachment and need careful consideration. Even though we did
not quantify the aﬃnity, it is clear from our data (Figure 8) that
the lifetime of the biotin-SAv bond on b-SAMs is drastically
reduced compared to its extremely high stability in solution.
We propose that this eﬀect is due to steric hindrance and/or
entropic costs arising from reduced conformational freedom of
ﬂexible OEG chains (biotinylated or not) in the SAM upon SAv
binding. In essence, the ﬂexible OEG linkers of the SAM layer
appear to exert a force that eﬀectively weakens the biotin-SAv
bond. This scenario is consistent with the high rigidity of the
SAM interface revealed by QCM-D (Figure S7B). As a result,
stable immobilization of SAv requires multivalent binding that
in turn occurs at suﬃciently high (≥1% in the case of HS-
(CH2)11-EG4-OH and HS-(CH2)11-EG6-biotin) fraction of
biotinylated thiols in b-SAMs. This suggests that earlier studies
reporting weakened interactions between rSAv and b-
SAMs,34,35,56 may have probed monovalent SAv/biotin binding.
Stable multivalent attachment to ﬂuid surfaces, regardless of
their biotin surface density (Figure 7B, blue), is expected and
can be explained by the ability of laterally mobile binding sites
Figure 8. SAv binding to sparsely biotinylated surfaces. (A) QCM-D
responses obtained during the binding of rSAv (squares), tSAv
(circles) and mSAv (lozenges) to b0.1%-SAMs. Binding is followed by
partial detachment, as illustrated schematically. (B) The QCM-D
response for the exposure of mSAv to b0.05%-SAM reveals rapid
unbinding upon rinsing in buﬀer (as illustrated schematically) and
repeatable binding.
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to diﬀuse to the binding pocket over long distances. Indeed,
assuming lb < 100 nm and a lipid diﬀusion constant Dlipid > 1




−2 s. This implies that two biotins will
get close to each other within a few milliseconds, which is much
shorter than the time scale of the SAv binding process (seconds
to minutes, Figure 6A).
Perhaps the most surprising ﬁnding of our study is that
mSAv is able to extract biotinylated lipids from lipid bilayers.
This eﬀect is reminiscent of the action of certain lipid transfer
proteins. Glycolipid transfer protein, for example, is known to
recognize glycolipids with high speciﬁcity and to facilitate their
extraction from lipid bilayers with the aid of a hydrophobic
pocket that harbors the lipid tail and thus eﬀectively solubilizes
the lipid.57,58 We do not know what the mechanism of lipid
extraction is in the case of mSAv but it appears possible that it
acts in a similar way through the binding of lipid tails into the
residual binding pockets. Since both mutated (inactive) and
native (active) biotin binding sites in our SAv constructs are
hydrophobic, it appears possible that not only mSAv but also
other SAv constructs, including regular SAv, have the intrinsic
ability to extract biotinylated lipids. This capacity, however, is
eﬀectively impaired when SAv binds multivalently to b-SLBs
and thus diﬃcult to observe directly for multivalent SAv
constructs.
Orientation of Bound SAv. Our data provide evidence
that SAv can attach stably to b-SLBs and b-SAMs in several
distinct ways: divalently with the two biotin-binding sites
arranged in either cis or trans positions, or trivalently (Figure
5C). This implies that the orientation of SAv on the surface
also diﬀers (Figure S11), and that the orientation correspond-
ing to two binding sites arranged in cis positionspreviously
identiﬁed in two-dimensional SAv crystals on SLBs and on lipid
monolayers at the air−water interface29,32,33is only one out
of several possible scenarios. Clearly, the arrangement of the
biotin binding pockets on SAv allows for various ways of biotin
binding, even though the linkers used for anchoring the biotin
moiety to the SLB and the SAM are relatively short: 1.3 nm and
1−2 nm (depending on EG6 stretching), respectively. The
access of biotins to two binding pockets in trans-orientation
and formation of trivalent bonds can be facilitated by the out-
of-plane mobility of lipids and the intrinsic ﬂexibility of the EG6
linker chain, respectively. Reorganization of ﬂexible loops on
SAv, and of lipids or OEG molecules, may then bring the
protein and the SLB/SAM even closer together and thereby
further aid the biotins to reach their binding pockets (Figure
S11). In particular, one can envisage the appearance of local
indentations in the SLB or SAM induced by the tight SAv
attachment (Figure S7B), where the degree of SAv insertion
into the immobile coating should strongly depend on the
characteristics of the OEG layer (i.e., OEG length, density and
organization).
Tuning the SAv Residual Valency. Our systematic
analysis demonstrates that the mean residual valency of SAv
can be tuned by surface chemistry (Figure 7). On immobile
surfaces, the mean residual valency is deﬁned by the SAM’s
biotin content and does not depend on the SAv surface
coverage. Speciﬁcally, maximal values close to 2.0 for rSAv and
1.0 for tSAv are attained at 1% biotin, and the residual valency
progressively decreases with higher biotin content as trivalent
attachment increases. The present data, together with previous
work8 suggest that values as low as 1.5 with rSAv and 0.5 with
tSAv can be attained at 20% biotin.
Somewhat less intuitively, the mean residual valency of SAv
on ﬂuid surfaces was found to increase with SAv surface
coverage. Several mechanisms can account for this behavior.
First, the steric hindrance aﬀecting dense monolayers may
prevent the rearrangement of SAv to form an additional third
bond with b-SLB. This may result in higher residual valency, in
particular if the formation of the third bond is the rate limiting
step. Second, SAv crystallization, known to occur in a divalent
mode at ﬂuid interfaces,29,32,33 may also contribute to the
increase of the residual valency with SAv coverage.
Furthermore, tuning SAv coverage through SAv incubation
time had a stronger eﬀect than tuning the SLB’s biotin content
on the residual valency (inset in Figure 7B, blue vs red). This
result suggests that the surface density of biotin does also play a
role in the regulation of SAv binding. In the case of diluted
(<1%) b-SLBs, the molar density of biotinylated lipids is about
a few pmol/cm2, which is comparable with ΓSAv. The formation
of purely trivalent complexes with diluted b-SLBs may thus be
restricted by the depletion of biotins (Figure 7B, blue). When
keeping the biotin coverage high (i.e., at least several times
higher than ΓSAv), the residual valency can be reduced to 1.0
sharply by shortening the SAv incubation time (Figure 7B, red).
The subtle dependence of SAv binding on b-SLB’s coverage
thereby allows one to tune the SAv residual valency from 1.0 to
2.0 (Figure 7B).
Summary and Implications. Our ﬁndings can be
summarized as follows:
(i) Monovalent binding, even if strong (femtomolar aﬃnity)
in solution, is not suﬃcient for the stable attachment of
SAv to commonly employed biotinylated surfaces.
(ii) On immobile but not on ﬂuid surfaces, stable (multi-
valent) SAv attachment requires a minimal surface
density of biotin binding sites.
(iii) The residual valency of surface-bound rSAv can vary
between 1 and 2, and depends sensitively on the surface
chemistry, with opposite trends on immobile and ﬂuid
surfaces.
SAv-governed self-assembly is currently used for the design
of functional interfaces suitable for numerous applications,
including sensors, biomaterials and nanomedicine.7−16 Our data
illustrate that eﬀects (i) and (ii) require serious consideration to
ensure interface functionality. Special attention should be given
to eﬀect (iii), since it may drastically aﬀect the eﬃciency of the
supramolecular assembly: when “gluing” nano-objects (e.g.,
capsules,19,20 viruses,21 particles22) together or attaching them
to the surface via SAv/biotin bonds, the SAv residual valency
should be kept close to 2 to ensure stable (multivalent)
attachment from both sides. Our data show immobile surfaces
with moderately diluted biotin content (e.g., b1%-SAMs, lb ≈ 5
nm) as well as ﬂuid membranes with dense biotin packing (e.g.,
b ≥ 5%-SLBs, lb ≤ 3.4 nm) to be optimal for such architectures.
Moreover, eﬀect (iii) also entails opportunities for the
quantitative tuning of residual valency, which can be
advantageously used for the development of model surfaces
displaying speciﬁc functionalities either individually or in
clusters of two via postmodiﬁcation of SAv at residual valency
1 or 2, respectively. Such a model could be used, for instance, to
probe the eﬀect of dimeric vs monomeric presentation of cell-
membrane ligands or receptors like cytokines, hormones,
cadherins, hyaladherinswith dimerization being a ubiquitous
signaling mechanism, whose impact on multivalent binding and
Journal of the American Chemical Society Article
DOI: 10.1021/jacs.7b00540
J. Am. Chem. Soc. XXXX, XXX, XXX−XXX
I
resulting biological functions (cell development, adhesion,
immune response, etc.) is not well studied.59,60
■ CONCLUSIONS
We have developed a well-deﬁned, highly speciﬁc and tunable
model system to identify the parameters governing the
orientation and residual valency of SAv at biotinylated
interfaces. Using the SAv/biotin pair as a model system, we
have demonstrated that the stoichiometry of multivalent
binding is essentially governed, and can thus be tuned, by the
surface chemistry. In addition, we found that monovalent
anchoring to the surface is not stable, even in the case of high
aﬃnity interactions, like between SAv and biotin, and may lead
to the extraction of functional molecules from laterally mobile
coatings. Our study should extend the practical applications of
the SAv/biotin technology, in particular in the design of robust
biomimetic and bioactive supramolecular assemblies at
interfaces. The obtained knowledge about the interplay
between surface chemistry, binding stability and residual
valency should also be useful to control surface binding of
other rigid multivalent scaﬀolds (i.e., proteins, nanoparticles,
and dendrimers),3 thus contributing to the general under-
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P. D.; Loṕez, G. P.; Klumb, L. A.; Stayton, P. S. J. Am. Chem. Soc.
1999, 121 (27), 6469.
Journal of the American Chemical Society Article
DOI: 10.1021/jacs.7b00540
J. Am. Chem. Soc. XXXX, XXX, XXX−XXX
J
(35) Bacharouche, J.; Badique, F.; Fahs, A.; Spanedda, M. V.;
Geissler, A.; Malval, J.-P.; Vallat, M.-F.; Anselme, K.; Francius, G.;
Frisch, B.; Hemmerle,́ J.; Schaaf, P.; Roucoules, V. ACS Nano 2013, 7
(4), 3457.
(36) Singh, S.; Lapin, N.; Singh, P. K.; Khan, M. A.; Chabal, Y. J. In
AIP Conference Proceedings; AIP Publishing, 2009; Vol. 1147, pp 443−
449.
(37) Wong, J.; Chilkoti, A.; Moy, V. T. Biomol. Eng. 1999, 16 (1−4),
45.
(38) Fairhead, M.; Krndija, D.; Lowe, E. D.; Howarth, M. J. Mol. Biol.
2014, 426 (1), 199.
(39) Stayton, P. S.; Freitag, S.; Klumb, L. A.; Chilkoti, A.; Chu, V.;
Penzotti, J. E.; To, R.; Hyre, D.; Le Trong, I.; Lybrand, T. P.;
Stenkamp, R. E. Biomol. Eng. 1999, 16 (1−4), 39.
(40) Loosli, A.; Rusbandi, U. E.; Gradinaru, J.; Bernauer, K.;
Schlaepfer, C. W.; Meyer, M.; Mazurek, S.; Novic, M.; Ward, T. R.
Inorg. Chem. 2006, 45 (2), 660.
(41) Walvoort, M. T. C.; Volbeda, A. G.; Reintjens, N. R. M.; van den
Elst, H.; Plante, O. J.; Overkleeft, H. S.; van der Marel, G. A.; Codeé, J.
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